MX2017014439A - Composicion para el tratamiento de parasitosis por gregarinas en camarones. - Google Patents

Composicion para el tratamiento de parasitosis por gregarinas en camarones.

Info

Publication number
MX2017014439A
MX2017014439A MX2017014439A MX2017014439A MX2017014439A MX 2017014439 A MX2017014439 A MX 2017014439A MX 2017014439 A MX2017014439 A MX 2017014439A MX 2017014439 A MX2017014439 A MX 2017014439A MX 2017014439 A MX2017014439 A MX 2017014439A
Authority
MX
Mexico
Prior art keywords
gregarine
infestation
shrimp
composition
methyl
Prior art date
Application number
MX2017014439A
Other languages
English (en)
Inventor
Sarfati Mizrahi David
Soto Priante Ernesto
Lozano Dubernard Bernardo
ROJAS CASTELLANOS Arturo
Original Assignee
Grupo Ind Pecuario S A De C V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grupo Ind Pecuario S A De C V filed Critical Grupo Ind Pecuario S A De C V
Publication of MX2017014439A publication Critical patent/MX2017014439A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

Abstract

Se ha inventado una composición para el tratamiento en contra de la parasitosis por gregarinas en camarones, caracterizada porque comprende un compuesto activo que se selecciona entre lasolacida, salinomicina, narasina, maduramicina, semduramicina, ácido 3-nitro fenil arsónico, ácido arsanílico, amprolio, decoquinato, diclazuril, etopabato, halofuginona, lasalocid, maduramicina, metilclorpindol, monensina, narasin, nicarbacina, robenidina, salinomicina sódica, semduramicina sódica, toltrazuril (1-metil-3-[3-metil-4-[4-(trifluorometil)tio)fenoxil]fenil]-1,3,5 -triazina(1H,3H,5H)-2,4,6-triona), o trimetoprim (5-[(3,4,5-trimetoxifenil)metil]pirimidin-2,4-diamina), y opcionalmente otros compuestos o excipientes. Se encontró que con esta composición se logra el tratamiento seguro y eficaz de parasitosis por gregarinas en camarones.
MX2017014439A 2015-05-11 2015-05-11 Composicion para el tratamiento de parasitosis por gregarinas en camarones. MX2017014439A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2015/053459 WO2016181187A1 (es) 2015-05-11 2015-05-11 Composición para el tratamiento de parasitosis por gregarinas en camarones

Publications (1)

Publication Number Publication Date
MX2017014439A true MX2017014439A (es) 2018-03-02

Family

ID=57249567

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017014439A MX2017014439A (es) 2015-05-11 2015-05-11 Composicion para el tratamiento de parasitosis por gregarinas en camarones.

Country Status (4)

Country Link
BR (1) BR112017024363B1 (es)
EC (1) ECSP17081673A (es)
MX (1) MX2017014439A (es)
WO (1) WO2016181187A1 (es)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2008009818A (es) * 2008-07-31 2010-02-01 Avi Mex S A De C V Lab Combinacion coccidicida para uso veterinario.
JP5812285B2 (ja) * 2009-07-28 2015-11-11 日東紡績株式会社 デヒドロゲナーゼまたは対応する基質の測定方法および測定用キット

Also Published As

Publication number Publication date
ECSP17081673A (es) 2018-02-28
BR112017024363A2 (pt) 2018-07-31
BR112017024363B1 (pt) 2023-03-14
WO2016181187A1 (es) 2016-11-17

Similar Documents

Publication Publication Date Title
MX2022000826A (es) Composiciones de forma de dosificacion que comprenden un inhibidor de tirosina cinasa de bruton.
PH12018500284A1 (en) 5-bromo-2,6-di-(1h-pyrazol-1-yl)pyrimidin-4-amine for use in the treatment of cancer
WO2016142855A3 (en) Pyrazolo[1,5-a][1,3,5]triazine and pyrazolo[1,5-a]pyrimidine derivatives as cdk inhibitors
MX2022001656A (es) Dispersiones solidas que comprenden estimulador de heme guanilato ciclasa soluble (sgc).
TN2016000227A1 (fr) Pyrrolo[2,3-d]pyrimidinyle, pyrrolo[2,3-b]pyrazinyle et pyrollo[2,3-d]pyridinyle acrylamides.
EA201890001A1 (ru) Замещенные гетероциклические производные как ингибиторы циклинзависимой киназы (cdk)
PH12016501203B1 (en) Crystalline forms of antiviral sofosbuvir analogues
MX2017001540A (es) Tabletas de rucaparib de dosificacion elevada.
PE20170189A1 (es) Nuevos derivados de pirazolo pirimidina y su uso como inhibidores de malt1
NZ627277A (en) Imidazopyrrolidinone compounds
RU2021102805A (ru) 4,6-ЗАМЕЩЕННЫЕ ПИРАЗОЛО[1,5-a]ПИРАЗИНЫ В КАЧЕСТВЕ ИНГИБИТОРОВ ЯНУС-КИНАЗЫ
MX365313B (es) Composición farmacéutica oral que comprende a,a,a-trifluorotimidin a y clorhidrato de 5-cloro-6-(2-iminopirrolidina-1-il)metil-2,4(1h ,3h)-pirimidina diona.
MA39361A1 (fr) Dispersion solide amorphe comprenant un taxane, comprimé contenant la dispersion, et méthode de préparation associée
EP4249071A3 (en) Benzoazepine analogs as inhibiting agents for bruton's tyrosine kinase
IL257872A (en) Crystalline form of 2-(2,6-dichlorophenyl)-1-[(1s,3r)-3-(hydroxymethyl)-5-(3-hydroxy-3-methylbutyl)-1-methyl-3,4-dihydroisoquinolin-2(1h)-yl]ethanone for the treatment of parkinson's disease
MY155922A (en) Oral administrable pharmaceutical composition
RU2018115716A (ru) Пиранодипиридиновое соединение
PE20160666A1 (es) Derivados de etinilo
SI3596080T1 (sl) Farmakološko aktivni aliciklični-substituirani pirazolo-(1,5-a)pirimidinski derivati
WO2018102670A3 (en) Method of treating cancer and method of sensitizing cancer cells to the action of chemotherapeutic agents via growth hormone receptor antagonists or knock down
MX2017014439A (es) Composicion para el tratamiento de parasitosis por gregarinas en camarones.
PH12015502661A1 (en) (+)-5-(3,4-difluorophenyl)-5-[(3-methyl-2-oxopyridin-1(2h)-yl)methyl]imidazolidine-2,4-dione and drug containing same
WO2016167511A3 (ko) N2-(2-메톡시페닐)피리미딘 유도체, 이의 제조 방법 및 이를 유효 성분으로 함유하는 암의 예방 또는 치료용 약학적 조성물
GT201700241A (es) Composición para el tratamiento de parasitosis por gregarinas en camarones
EA201690762A1 (ru) {4-[5-(3-хлорфенокси)оксазоло[5,4-d]пиримидин-2-ил]-2,6-диметилфенокси}уксусная кислота для применения при предупреждении или лечении острого повреждения почек